Safety & Side Effects

1. Know what the evidence actually says

Check the research-status badge on each peptide page. Preclinical means the safety and benefit data is mostly animal/in-vitro. Approved (semaglutide, tirzepatide) means there’s real human trial data and a regulated pathway — and a prescriber. Match your confidence to the evidence.

2. Common side effects

Across many peptides, the commonly-reported effects are:

• Injection-site reactions — redness, irritation, lump at the injection site (most injectable peptides).
• GI upset — nausea, changes in appetite (notably GLP-1s).
• Water retention / mild edema — reported with several growth-hormone-related peptides.
• Flushing, headache, fatigue — generally mild and transient.

Each peptide page lists the specific side effects drawn from its sourced research, each with a reliability score so you can see how well-established it is.

3. Contraindications + what to avoid

• Pregnancy / breastfeeding — avoid; safety data essentially absent for research peptides.
• Active cancer or history of cancer — some peptides affect pathways relevant to growth; medical guidance is essential.
• Combining many peptides at once — interactions are poorly characterized; change one variable at a time.
• Reusing supplies or non-sterile technique — the biggest real-world risk of injectables is infection, not the peptide.

4. When to stop and see a doctor

Stop immediately and seek care if you notice:

• Signs of infection (spreading redness, heat, pus, fever) at an injection site.
• An allergic reaction — rash, swelling of the lips/throat, wheezing, or difficulty breathing.
• Persistent or severe pain, or anything neurological (vision changes, numbness, severe headache).
• Unexpected cardiovascular effects (chest pain, palpitations, fainting).

These are not “normal” peptide effects — don’t explain them away.